Detalles de la búsqueda
1.
Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs: two phase 3 randomised trials (contRAst 1 and contRAst 2).
Ann Rheum Dis
; 82(12): 1516-1526, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37699654
2.
Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial (contRAst 3).
Ann Rheum Dis
; 82(12): 1527-1537, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37696589
3.
Efficacy and safety of mavrilimumab in Japanese subjects with rheumatoid arthritis: findings from a Phase IIa study.
Mod Rheumatol
; 25(1): 21-30, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24720551
4.
MRI of the joint and evaluation of the granulocyte-macrophage colony-stimulating factor-CCL17 axis in patients with rheumatoid arthritis receiving otilimab: a phase 2a randomised mechanistic study.
Lancet Rheumatol
; 2(11): e666-e676, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38279363
5.
Efficacy, patient-reported outcomes, and safety of the anti-granulocyte macrophage colony-stimulating factor antibody otilimab (GSK3196165) in patients with rheumatoid arthritis: a randomised, phase 2b, dose-ranging study.
Lancet Rheumatol
; 2(11): e677-e688, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38279364
6.
Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an inadequate response to background methotrexate therapy or an inadequate response or intolerance to an anti-TNF (tumour necrosis factor) biologic therapy: a randomized, controlled trial.
Arthritis Res Ther
; 21(1): 101, 2019 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-30999929
7.
Targeting GM-CSF in rheumatological conditions: risk of PAP - Authors' reply.
Lancet Rheumatol
; 3(7): e473-e474, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38279397
Resultados
1 -
7
de 7
1
Próxima >
>>